Inspire Medical Systems, Inc. (INSP): Price and Financial Metrics
GET POWR RATINGS... FREE!
INSP POWR Grades
- INSP scores best on the Growth dimension, with a Growth rank ahead of 55.02% of US stocks.
- The strongest trend for INSP is in Growth, which has been heading up over the past 198 days.
- INSP's current lowest rank is in the Value metric (where it is better than 15.29% of US stocks).
INSP Stock Summary
- INSP's went public 3.01 years ago, making it older than merely 8.76% of listed US stocks we're tracking.
- With a price/sales ratio of 40.07, Inspire Medical Systems Inc has a higher such ratio than 93.79% of stocks in our set.
- As for revenue growth, note that INSP's revenue has grown 54.21% over the past 12 months; that beats the revenue growth of 90.55% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Inspire Medical Systems Inc, a group of peers worth examining would be SWAV, PHR, AWH, BLDP, and PRLB.
- INSP's SEC filings can be seen here. And to visit Inspire Medical Systems Inc's official web site, go to www.inspiresleep.com.
INSP Stock Price Chart Interactive Chart >
INSP Price/Volume Stats
|Current price||$197.88||52-week high||$252.25|
|Prev. close||$226.53||52-week low||$65.71|
|Day high||$205.64||Avg. volume||223,901|
|50-day MA||$217.95||Dividend yield||N/A|
|200-day MA||$173.18||Market Cap||5.38B|
Inspire Medical Systems, Inc. (INSP) Company Bio
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is based in Maple Grove, Minnesota.
INSP Latest News Stream
|Loading, please wait...|
INSP Latest Social Stream
View Full INSP Social Stream
Latest INSP News From Around the Web
Below are the latest news stories about Inspire Medical Systems Inc that investors may wish to consider to help them evaluate INSP as an investment opportunity.
Inspire Medical Systems (INSP) announces an exclusive distribution agreement with Japan Lifeline Co., Ltd. ((JLL)), a service distributor of medical devices, to commercialize Inspire therapy in Japan.The parties entered into this agreement following successful completion of reimbursement review of Inspire therapy by the Minister of Health Labour and Welfare ((MLHW)).Formal...
Inspire Medical Systems, Inc. Announces Exclusive Distribution Agreement with Japan Lifeline Co., Ltd to Commercialize Inspire Therapy in Japan
Reimbursement Review of Inspire Therapy Completed by Japan Ministry of Health Labour and Welfare (MHLW); National Health Insurance Payment Listing Expected in June 2021 Initial Inspire Therapy Implants in Japan Anticipated to Occur in Second Half of 2021 MINNEAPOLIS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), today announced an exclusive distribution agreement with Japan Lifeline Co., Ltd. (“JLL”), an independent full-service distributor of medical devices, to commercialize Inspire therapy in Japan. The parties entered into this agreement following successful ...
In this episode of Industry Focus: Wildcard, join Motley Fool contributor Brian Feroldi and host Emily Flippen as they talk about three companies trying to treat sleep apnea: ResMed (NYSE: RMD), Inspire Medical (NYSE: INSP), and Vivos Therapeutics (NASDAQ: VVOS). To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Today is Wednesday, March 24th, and I am your host, Emily Flippen.
MINNEAPOLIS, April 06, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the first quarter 2021 after the close of trading on Tuesday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. Tuesday, May 4th @ 5:00 p.m. Eastern Time:Domestic: 877-407-0792International: 201-689-8263Conference ID: 13717525Webcast: http://public.viavid.com/index.php?id=143909 About Inspire Medical SystemsInspire is a medical technolo...
Medical technology company Inspire Medical Systems received approval from the U.S. Food and Drug Administration (FDA) for the Inspire physician programmer platform. Inspire Medical Systems (INSP) is focused on minimally invasive solutions for treating patients with obstructive sleep apnea. The approved platform provides four major enhancements to the company’s existing product. These enhancements include guided workflows, a new programmer cable that allows for ease of use, and improved telemetry range. The platform enables interface with Inspire cloud and uploading patient reports. It also supports the further integration of Inspire cloud, which can potentially provide remote programming, a feature that is currently under development.
INSP Price Returns
Continue Researching INSPWant to do more research on Inspire Medical Systems Inc's stock and its price? Try the links below:
Inspire Medical Systems Inc (INSP) Stock Price | Nasdaq
Inspire Medical Systems Inc (INSP) Stock Quote, History and News - Yahoo Finance
Inspire Medical Systems Inc (INSP) Stock Price and Basic Information | MarketWatch